Endogenous Nanoparticles as Biomarkers and Nanocarriers
A special issue of Micromachines (ISSN 2072-666X). This special issue belongs to the section "B：Biology and Biomedicine".
Deadline for manuscript submissions: closed (15 October 2021) | Viewed by 328
Special Issue Editor
Interests: lung inflammation; injury and repair; lung diseases; non-coding RNA; exosomes and nanoparticles as biomarkers and therapeutic tools; immunomodulation in cancer; stem cell based therapy; extracellular matrix in organ homeostasis and inflammation
Special Issue Information
Dear Colleagues,
Extracellular vesicles (EVs) considered endogenous nanoparticles, are rapidly emerging as an exciting field of cell biology, because of their potential use as biomarkers and therapeutic nanocarriers. Similar to the synthetic drug delivery nanoparticle systems, extracellular vesicles are capable of delivering a complex cargo of proteins, lipids and nucleic acids, and are important mediators of intra and inter-cellular communications. The aim of this special issue is to provide an overall understanding of the biogenesis, the role and the applications of EVs in normal and pathological conditions and a comparison between extracellular vesicles and nanoparticles as diagnostic and therapeutic tools.
Specific areas of interest include, but are not limited to the following topics:
- Biogenesis and role of extracellular vesicles in disease.
- Extracellular vesicles isolation, characterization, quantification and applications.
- Extracellular vesicles and nanoparticles, for diagnostic and drug delivery.
- Extracellular vesicles as biomarkers and therapeutic tools.
- Extracellular vesicles and nanoparticles as immune-mediators in disease.
- Engineered extracellular vesicles and nanoparticles in cancer and other chronic diseases.
- Noncoding RNA, including long non-coding RNA, miRNA and circular RNA containing extracellular vesicles and nanoparticles as biomarkers and therapeutic tools.
- Role of the stem cell-derived extracellular vesicles in cell differentiation and repair.
- Extracellular vesicles and nanoparticles uptake mechanism.
- Extracellular vesicles high-throughput screening data, including next-generation sequencing, proteomics, lipidomics and metabolomics.
Dr. Maria Cristina Munteanu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Micromachines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Extracellular vesicles
- microvesicles
- exosomes
- ectosomes
- apoptotic bodies
- nanoparticles
- stem cells
- cancer
- drug delivery
